Biologic Drugs

Jun 22, 2018
By Pharmaceutical Technology Editors
The three-year collaboration will focus on developing vaccines for up to five infectious disease pathogens.
Jun 22, 2018
By Pharmaceutical Technology Editors
The company has completed the first phase of expansion at its headquarters in Freiburg, Germany, in anticipation of increasing demand as cell and gene therapies approach commercialization.
Jun 21, 2018
By Pharmaceutical Technology Editors
The contract development and manufacturing company has received an additional approval from Health Canada to manufacture monoclonal antibody drug substance at its first plant in Icheon, South Korea.
Jun 08, 2018
By Pharmaceutical Technology Editors
MilliporeSigma targets emerging biotechs with US development center and global grants.
Jun 07, 2018
By Pharmaceutical Technology Editors
The company will provide the first FlexFactory manufacturing platform for TCR T-cell therapy manufacturing.
Jun 07, 2018
By Pharmaceutical Technology Editors
A new report released at the BIO International Convention shows that the US bioscience industry has had a $2-trillion economic impact and has accelerated venture capital investment and job growth.
Jun 04, 2018
By Pharmaceutical Technology Editors
EMA has recommended marketing authorization for Aimovig (erenumab), a new treatment for migraine.
Jun 04, 2018
By Pharmaceutical Technology Editors
The agency has recommended approval of three biosimilar adalimumab products from Novartis, referencing AbbVie’s Humira, and a biosimilar trastuzumab from Pfizer, referencing Roche’s Herceptin.
May 30, 2018
By Pharmaceutical Technology Editors
GE Healthcare and the Centre for Commercialization of Regenerative Medicine (CCRM) will support scale-up efforts by DiscGenics for a new cell therapy intended to treat back pain.
May 29, 2018
By Pharmaceutical Technology Editors
The European Commission has approved Zessly (infliximab), a biosimilar to Johnson & Johnson’s blockbuster Remicade (infliximab).
native1_300x100
lorem ipsum